New Key Statistics Module, Z-Score and F-Score
AMEX:MTNB Key Ratios
| Market Cap $ M | 2.63 |
| Enterprise Value $ M | -5.09 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.17 |
| Price/Sales | 2.06 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 1.00 |
| EPS (TTM) $ | -4.79 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | 6.30 |
| 5-y EBITDA Growth Rate % | 5.90 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 0.23 |
| EV-to-EBITDA | 0.24 |
| PEG | -- |
| Shares Outstanding M | 5.09 |
| Net Margin (%) | -- |
| Operating Margin % | -- |
| Pre-tax Margin (%) | -- |
| Quick Ratio | 5.53 |
| Current Ratio | 5.53 |
| ROA % (ttm) | -88.46 |
| ROE % (ttm) | -115.05 |
| ROIC % (ttm) | -219.15 |
| Dividend Yield % | -- |
| Altman Z-Score | -- |
MTNB Number of Guru Trades
MTNB Volume of Guru Trades
Gurus Latest Trades with AMEX:MTNB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
AMEX:MTNB is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Matinas BioPharma Holdings Inc Insider Transactions
No Available Data
News about AMEX:MTNB
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers